OPKO Health Statistics

Total Valuation

OPKO Health has a market cap or net worth of ILS 2.80 billion. The enterprise value is 2.90 billion.

Market Cap	2.80B
Enterprise Value	2.90B

Important Dates

The last earnings date was Thursday, February 26, 2026.

Earnings Date	Feb 26, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	759.07M
Shares Outstanding	n/a
Shares Change (YoY)	+8.23%
Shares Change (QoQ)	-1.85%
Owned by Insiders (%)	42.38%
Owned by Institutions (%)	25.49%
Float	339.36M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.45
PB Ratio	0.69
P/TBV Ratio	12.14
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-4.03
EV / Sales	1.54
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-4.77

Financial Position

The company has a current ratio of 3.97, with a Debt / Equity ratio of 0.31.

Current Ratio	3.97
Quick Ratio	3.21
Debt / Equity	0.31
Debt / EBITDA	n/a
Debt / FCF	-2.08
Interest Coverage	-2.02

Financial Efficiency

Return on equity (ROE) is -17.14% and return on invested capital (ROIC) is -16.92%.

Return on Equity (ROE)	-17.14%
Return on Assets (ROA)	-6.62%
Return on Invested Capital (ROIC)	-16.92%
Return on Capital Employed (ROCE)	-12.27%
Weighted Average Cost of Capital (WACC)	15.30%
Revenue Per Employee	850,431
Profits Per Employee	-316,250
Employee Count	2,997
Asset Turnover	0.29
Inventory Turnover	7.56

Taxes

Income Tax	-50.09M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -38.00% in the last 52 weeks. The beta is 1.49, so OPKO Health's price volatility has been higher than the market average.

Beta (5Y)	1.49
52-Week Price Change	-38.00%
50-Day Moving Average	397.68
200-Day Moving Average	441.87
Relative Strength Index (RSI)	45.83
Average Volume (20 Days)	259,332

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	9.83

Income Statement

In the last 12 months, OPKO Health had revenue of ILS 1.93 billion and -719.47 million in losses. Loss per share was -0.96.

Revenue	1.93B
Gross Profit	261.12M
Operating Income	-698.12M
Pretax Income	-769.56M
Net Income	-719.47M
EBITDA	-406.02M
EBIT	-698.12M
Loss Per Share	-0.96

Full Income Statement

Balance Sheet

The company has 1.16 billion in cash and 1.26 billion in debt, giving a net cash position of -103.21 million.

Cash & Cash Equivalents	1.16B
Total Debt	1.26B
Net Cash	-103.21M
Net Cash Per Share	n/a
Equity (Book Value)	4.04B
Book Value Per Share	5.33
Working Capital	1.39B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -569.19 million and capital expenditures -39.14 million, giving a free cash flow of -608.33 million.

Operating Cash Flow	-569.19M
Capital Expenditures	-39.14M
Free Cash Flow	-608.33M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 13.50%, with operating and profit margins of -36.08% and -37.19%.

Gross Margin	13.50%
Operating Margin	-36.08%
Pretax Margin	-39.78%
Profit Margin	-37.19%
EBITDA Margin	-20.99%
EBIT Margin	-36.08%
FCF Margin	n/a

Dividends & Yields

OPKO Health does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-8.23%
Shareholder Yield	-8.23%
Earnings Yield	-25.68%
FCF Yield	-21.72%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

OPKO Health has an Altman Z-Score of -0.48 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-0.48
Piotroski F-Score	3